Stay updated on Pembrolizumab/Vibostolimab vs Pembrolizumab in Melanoma Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab/Vibostolimab vs Pembrolizumab in Melanoma Clinical Trial page.

Latest updates to the Pembrolizumab/Vibostolimab vs Pembrolizumab in Melanoma Clinical Trial page
- CheckyesterdayChange DetectedA new history entry on 2026-07-24 adds a Terminated status with a Business Reason and updates Study/Recruitment Status. The prior Completed entry from 2025-10-15 is removed.SummaryDifference0.4%

- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedThe history shows the record updated to revision v3.6.5, replacing the previous v3.6.4. This indicates a new version of the page was published.SummaryDifference0.1%

- Check22 days agoNo Change Detected
- Check30 days agoChange DetectedA new revision entry labeled v3.6.4 was added to the history, updating the page's version label. This is a metadata change and does not modify core trial information or user-facing content.SummaryDifference0.1%

- Check51 days agoChange DetectedA new revision entry v3.6.3 was added to the record history, replacing the previous v3.6.2.SummaryDifference0.1%

- Check58 days agoChange DetectedA new revision entry (v3.6.2) was added to the record history, replacing the previous revision (v3.6.0) to reflect an update to the page's version metadata.SummaryDifference0.1%

- Check72 days agoChange DetectedRecruitment status is updated to 'No longer looking for participants' in the study history. The record revision is updated to v3.6.0, replacing the prior v3.5.5.SummaryDifference0.2%

Stay in the know with updates to Pembrolizumab/Vibostolimab vs Pembrolizumab in Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab/Vibostolimab vs Pembrolizumab in Melanoma Clinical Trial page.